AMPK and Polycystic Kidney Disease Drug Development: An Interesting Off-Target Target
Open Access
- 31 January 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 753418
Abstract
Autosomal Dominant Polycystic Kidney Disease is a genetic disease that causes dramatic perturbations of both renal tissue architecture and of a multitude of cellular signaling pathways. The relationship between the products of the genes whose mutations cause polycystic kidney disease and these signaling pathways remains difficult to determine. It is clear, however, that cellular metabolism is dramatically altered in cells that are affected by polycystic kidney disease mutations. Adenosine monophosphate-stimulated protein kinase is a master regulator of cellular energy use and generation pathways whose activity appears to be perturbed in cells affected by polycystic kidney disease. Furthermore, modulation of this enzyme's activity may constitute a promising approach for the development of new therapeutics for polycystic kidney disease.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 67 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- The Ancient Drug Salicylate Directly Activates AMP-Activated Protein KinaseScience, 2012
- Polycystic kidney disease: Pathogenesis and potential therapiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Activating AMP-activated protein kinase (AMPK) slows renal cystogenesisProceedings of the National Academy of Sciences, 2011
- The cell biology of polycystic kidney diseaseJournal of Cell Biology, 2010
- Primary cilia regulate mTORC1 activity and cell size through Lkb1Nature Cell Biology, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)Nephrology Dialysis Transplantation, 2009
- Polycystic Kidney DiseaseAnnual Review of Medicine, 2009
- AMP-activated/SNF1 protein kinases: conserved guardians of cellular energyNature Reviews Molecular Cell Biology, 2007